Answer: C. scorpions have changed as a result of natural selection
Explanation:
The text tells us that scorpions today are now smaller than they were in the past. This means that the scorpions have changed since then i.e. they have evolved.
The primary reason for evolution is natural selection which refers to a situation whereby only the organisms that are better adapted in their species survive.
The conclusion that can be drawn from this research therefore is that we have smaller scorpions today because they stood a better chance of survival than the larger ones and so survived whilst the larger ones died out.
1- C ( this is an assumption; a hypothesis is always based on an assumption.
2- F ( this states to share the results with other classmates).
3- D (this is a description of an experiment you could conduct; you test a hypothesis (usually) by conducting an experiment.
4- A (this is something you could observe during the experiment, therefore it is an observation).
5- E (this sentence is a conclusion).
6- B (This is an actual question)
Explanation:
When current passes through the wires inside the bulb, electrical energy changes into heat energy and light energy. ... All parts of a circuit must be connected in order for current to flow through the circuit.
A,b I think should be the answer
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
